A unique opportunity for global leaders in Fragile X research to gather, network and share ideas.
Barcelona, Spain
November 7-8, 2004
- Diagnosis and newborn screening
- Holistic care for infants, teens and adults
- Medical therapies and outcome
- measures
- FXPAC: FXTAS, FXPOI and other FMR1
- premutation-associated issues
- Mosaicism and biomarkers
- in FXS and FXPAC
- The future of Fragile X